Klingenstein Fields & Co’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.79M Buy
90,291
+358
+0.4% +$23.6K 0.23% 73
2025
Q4
$5.62M Buy
89,933
+43,985
+96% +$2.69M 0.21% 75
2025
Q3
$2.75M Buy
45,948
+38,718
+536% +$2.26M 0.1% 86
2025
Q2
$412K Sell
7,230
-100
-1% -$5.36K 0.02% 128
2025
Q1
$373K Hold
7,330
0.02% 130
2024
Q4
$351K Hold
7,330
0.01% 134
2024
Q3
$387K Hold
7,330
0.02% 134
2024
Q2
$362K Hold
7,330
0.02% 133
2024
Q1
$368K Hold
7,330
0.02% 135
2023
Q4
$351K Buy
7,330
+1,250
+21% +$56K 0.02% 131
2023
Q3
$266K Hold
6,080
0.01% 148
2023
Q2
$281K Hold
6,080
0.01% 144
2023
Q1
$275K Hold
6,080
0.01% 144
2022
Q4
$255K Hold
6,080
0.01% 156
2022
Q3
$221K Buy
+6,080
New +$248K 0.01% 162
2021
Q3
Sell
-4,431
Closed -$228K 208
2021
Q2
$228K Buy
4,431
+4
+0.1% +$206 0.01% 182
2021
Q1
$217K Buy
+4,427
New +$216K 0.01% 180

Other funds holding VEA

Klingenstein Fields & Co's VEA Position: Q1 2026 in Review

Klingenstein Fields & Co increased its Vanguard FTSE Developed Markets ETF (VEA) stake by 0.4% in Q1 2026, buying an estimated $23.6K and bringing the position to 90,291 shares worth $5.79M. The position accounts for 0.23% of the portfolio, ranked #73.

Klingenstein Fields & Co first reported a position in VEA in Q1 2021 and has held it in 17 quarters since. 2,891 funds tracked by Wall St. Rank hold VEA as of Q1 2026.

  • Klingenstein Fields & Co held 90,291 shares of Vanguard FTSE Developed Markets ETF worth $5.79M as of Q1 2026.
  • Klingenstein Fields & Co bought 358 Vanguard FTSE Developed Markets ETF shares in Q1 2026, an estimated $23.6K.
  • Vanguard FTSE Developed Markets ETF made up 0.23% of Klingenstein Fields & Co's portfolio in Q1 2026, its #73 holding.
  • Klingenstein Fields & Co first reported a position in Vanguard FTSE Developed Markets ETF in Q1 2021 and has held it in 17 quarters since.
  • 2,891 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q1 2026.

Based on Klingenstein Fields & Co's 13F filing for Q1 2026, filed 13 May 2026.